drugset / Trial / NCT03283670

Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies

NCT03283670

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study aims to determine whether different concentrations of nitrous oxide (N2O) have different antidepressant effects for adults with treatment-resistant major depression.

Timeline

Start
2016-11-22
Primary completion
2020-02-18
Completion
2020-02-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrous Oxide Other / unclassified 25 % Inhaled
Subject Nitrous Oxide Other / unclassified 50 % Inhaled